A single sharps injury can cost a healthcare facility anywhere from a few hundred dollars for a low-risk exposure to well over $5,000 when post-exposure medications, follow-up testing, and lost productivity are factored in. But the full picture is broader than most people expect, spanning medical evaluation, preventive drug therapy, lost work time, psychological harm, and potential regulatory penalties. If a worker actually contracts a bloodborne infection, lifetime costs can reach six figures.
Immediate Medical Costs
The moment a sharps injury is reported, a chain of medical steps begins: wound care, a risk assessment, baseline blood draws from the injured worker, and ideally testing of the source patient. A physician or occupational health nurse evaluates the exposure type, the source’s infection status, and the worker’s vaccination history. A systematic review in Infection Control & Hospital Epidemiology found that the median direct medical costs for evaluating a sharps injury typically fall in the range of several hundred international dollars, though the number climbs quickly depending on what happens next.
If the source patient is positive for HIV, the injured worker is started on a 28-day course of antiretroviral medications to reduce the chance of infection. This regimen requires its own set of lab tests (kidney function, liver enzymes, blood counts) at multiple points during and after treatment. The drugs alone can cost over $1,000, and the side effects sometimes force workers off the job for days.
Infection Risk and Long-Term Treatment
The financial stakes depend heavily on which pathogen is involved. The three main bloodborne viruses transmitted through needlesticks carry very different transmission rates per injury:
- Hepatitis B: 6% to 30% risk of infection from an unvaccinated exposure, the highest of the three. Vaccination has dramatically reduced this threat, but unvaccinated or under-vaccinated workers remain vulnerable.
- Hepatitis C: roughly 1.8% infection rate per needlestick from a positive source.
- HIV: approximately 0.3%, or about 3 in every 1,000 exposures.
These percentages sound small, but the consequences of actual infection are enormous. The estimated lifetime medical cost for a person who develops chronic hepatitis C is about $90,000 with treatment and nearly $156,000 without it. For patients who progress to cirrhosis, that figure jumps: untreated cirrhosis carries lifetime costs approaching $200,000, and decompensated cirrhosis (where the liver begins to fail) can exceed $208,000. HIV treatment is a lifelong commitment with costs that can easily surpass these figures over decades. A single needlestick that results in seroconversion transforms a momentary accident into a chronic, expensive medical condition.
Lost Productivity and Missed Work
Even when no infection occurs, sharps injuries eat into work time. The injured worker has to stop what they’re doing, report the incident, visit occupational health, get blood drawn, and return for follow-up appointments at 6 weeks, 3 months, and sometimes 6 months. A clinician has to evaluate the exposure. Supervisors have to file reports. Across studies, the median indirect costs from lost productivity alone range between $175 and $350 per incident.
That figure captures only the routine, uncomplicated cases. In a study of 110 U.S. nurses who reported lost time after a needlestick, a collective 77 workdays were missed. Ten of those days were spent seeking medical attention, six were lost to side effects from HIV prophylaxis medication, and 61 were missed due to emotional distress and anxiety. The replacement labor, overtime pay, and scheduling disruption those absences create add costs that rarely appear on any single invoice but accumulate across a facility.
Psychological and Emotional Toll
The costs that are hardest to quantify may also be the most significant for the individual worker. In one study of 313 healthcare workers who experienced a needlestick, 41.8% reported feeling anxious, depressed, or stressed afterward. Another study found anxiety in over 80% of affected workers, with nearly 14% experiencing persistent anxiety that didn’t resolve on its own. Physicians who sustained a needlestick were more than four times as likely to show signs of post-traumatic stress disorder.
The psychological impact is especially severe when the source patient is known to have HIV. Nurses who tested negative for nearly two years after their injury still displayed symptoms consistent with PTSD, insomnia, depression, nightmares, and panic attacks when returning to the unit where the injury occurred. Counseling for injured workers is a recognized cost component, and the need for it can persist long after the medical follow-up is complete.
A willingness-to-pay analysis found that healthcare workers would pay a median of $828 out of pocket to avoid a sharps injury, and $1,237 if the source was known to be HIV- or hepatitis C-positive. That figure roughly equals the cost of the medical evaluation itself, suggesting that the emotional burden of a needlestick doubles its true cost to the person who experiences it.
Regulatory Fines and Legal Exposure
Employers who fail to protect workers from sharps injuries face financial consequences from OSHA as well. The Bloodborne Pathogens Standard requires healthcare facilities to use safety-engineered devices, maintain a sharps injury log, and provide training. As of January 2025, a serious violation carries a maximum penalty of $16,550 per violation. A willful or repeated violation can reach $165,514. Failure to correct a cited hazard costs up to $16,550 per day beyond the deadline.
Beyond federal fines, facilities can face workers’ compensation claims, lawsuits, and increased insurance premiums. A pattern of injuries signals systemic problems that multiply legal exposure. For multi-site healthcare systems, these costs can scale rapidly if the same deficiency exists across locations.
Prevention Pays for Itself
Switching from conventional needles and scalpels to safety-engineered devices costs more upfront, but the math favors prevention. A budget impact model based on a 420-bed hospital found that fully replacing conventional sharps with safety-engineered alternatives reduced needlestick injuries over five years from 310 to 75, a drop of more than 75%. The higher device acquisition costs (about €142,640 over five years) were more than offset by a €194,350 reduction in injury management costs, yielding a net savings of roughly €51,710, or 12% of total spending.
The model also showed that safety devices would still save money even if they only reduced injuries by 32%, a threshold well below their actual performance. The variables that most affected the outcome were the price difference between conventional and safety devices, and the baseline rate of injuries with conventional equipment. Hospitals with higher injury rates stand to save the most by switching.
For facilities weighing the cost of prevention against the cost of inaction, the numbers are clear: the upfront expense of safer devices is smaller than the cumulative burden of medical evaluations, lost work time, emotional harm, and the rare but catastrophic cost of a transmitted infection.